Biosignatures
Newcastle Upon Tyne
About Biosignatures
Biosignatures has the capability to reliably discover multiple protein based disease diagnostics. Four cancer diagnostic products are in development, one of which has passed it's first validation trial.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $4.2M
- Last round: Series Unknown (Aug 2019)
- Website: biosignatures.com
- Phone: +44 (0)191 645 3645
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/biosignatures-189609 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.